Literature DB >> 20087364

Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia.

Lisa C Hoyte1, Keith J Brooks, Simon Nagel, Asim Akhtar, Ruoli Chen, Sylvie Mardiguian, Martina A McAteer, Daniel C Anthony, Robin P Choudhury, Alastair M Buchan, Nicola R Sibson.   

Abstract

The pathogenesis of stroke is multifactorial, and inflammation is thought to have a critical function in lesion progression at early time points. Detection of inflammatory processes associated with cerebral ischemia would be greatly beneficial in both designing individual therapeutic strategies and monitoring outcome. We have recently developed a new approach to imaging components of the inflammatory response, namely endovascular adhesion molecule expression on the brain endothelium. In this study, we show specific imaging of vascular cell adhesion molecule (VCAM)-1 expression in a mouse model of middle cerebral artery occlusion (MCAO), and a reduction in this inflammatory response, associated with improved behavioral outcome, as a result of preconditioning. The spatial extent of VCAM-1 expression is considerably greater than the detectable lesion using diffusion-weighted imaging (25% versus 3% total brain volume), which is generally taken to reflect the core of the lesion at early time points. Thus, VCAM-1 imaging seems to reveal both core and penumbral regions, and our data implicate VCAM-1 upregulation and associated inflammatory processes in the progression of penumbral tissue to infarction. Our findings indicate that such molecular magnetic resonance imaging (MRI) approaches could be important clinical tools for patient evaluation, acute monitoring of therapy, and design of specific treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087364      PMCID: PMC2949202          DOI: 10.1038/jcbfm.2009.287

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression.

Authors:  F C Barone; R F White; P A Spera; J Ellison; R W Currie; X Wang; G Z Feuerstein
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

Review 2.  The role of cytokines in the neuropathology of stroke and neurotrauma.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Neuroimmunomodulation       Date:  1998 May-Aug       Impact factor: 2.492

3.  Preconditioning in vivo ischemia inhibits anoxic long-term potentiation and functionally protects CA1 neurons in the gerbil.

Authors:  K Kawai; T Nakagomi; T Kirino; A Tamura; N Kawai
Journal:  J Cereb Blood Flow Metab       Date:  1998-03       Impact factor: 6.200

4.  The expression of P- and E-selectins in three models of middle cerebral artery occlusion.

Authors:  R Zhang; M Chopp; Z Zhang; N Jiang; C Powers
Journal:  Brain Res       Date:  1998-03-02       Impact factor: 3.252

5.  Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke.

Authors:  E S Connolly; C J Winfree; C J Prestigiacomo; S C Kim; T F Choudhri; B L Hoh; Y Naka; R A Solomon; D J Pinsky
Journal:  Circ Res       Date:  1997-09       Impact factor: 17.367

6.  A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging.

Authors:  R Hata; G Mies; C Wiessner; K Fritze; D Hesselbarth; G Brinker; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1998-04       Impact factor: 6.200

7.  IL-10 reduces rat brain injury following focal stroke.

Authors:  P A Spera; J A Ellison; G Z Feuerstein; F C Barone
Journal:  Neurosci Lett       Date:  1998-07-31       Impact factor: 3.046

8.  Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia.

Authors:  K Kitagawa; M Matsumoto; T Mabuchi; Y Yagita; T Ohtsuki; M Hori; T Yanagihara
Journal:  J Cereb Blood Flow Metab       Date:  1998-12       Impact factor: 6.200

9.  Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.

Authors:  E S Connolly; C J Winfree; T A Springer; Y Naka; H Liao; S D Yan; D M Stern; R A Solomon; J C Gutierrez-Ramos; D J Pinsky
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 10.  Induced expression of adhesion molecules following focal brain ischemia.

Authors:  X Wang; G Z Feuerstein
Journal:  J Neurotrauma       Date:  1995-10       Impact factor: 5.269

View more
  23 in total

Review 1.  CMR for characterization of the myocardium in acute coronary syndromes.

Authors:  Erica Dall'Armellina; Theodoros D Karamitsos; Stefan Neubauer; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2010-09-21       Impact factor: 32.419

Review 2.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

3.  Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage.

Authors:  Dominic A Siler; Yosef A Berlow; Ayaka Kukino; Catherine M Davis; Jonathan W Nelson; Marjorie R Grafe; Hirohisa Ono; Justin S Cetas; Martin Pike; Nabil J Alkayed
Journal:  Stroke       Date:  2015-05-19       Impact factor: 7.914

4.  Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury.

Authors:  Stuart M Grieve; Jacob Lønborg; Jawad Mazhar; Timothy C Tan; Edwin Ho; Chia-Chi Liu; William Lay; Anthony J Gill; Philip Kuchel; Ravinay Bhindi; Gemma A Figtree
Journal:  Eur Biophys J       Date:  2012-09-28       Impact factor: 1.733

5.  Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

Authors:  Ann-Marie Chacko; Elizabeth D Hood; Blaine J Zern; Vladimir R Muzykantov
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-06       Impact factor: 6.448

6.  Possible involvement of oxidative stress and inflammatory mediators in the protective effects of the early preconditioning window against transient global ischemia in rats.

Authors:  Noha N Nassar; Rania M Abdelsalam; Abdel A Abdel-Rahman; Dalaal M Abdallah
Journal:  Neurochem Res       Date:  2011-11-24       Impact factor: 3.996

7.  Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases.

Authors:  Oran Erster; Jerry M Thomas; Juliana Hamzah; Abeer M Jabaiah; Jennifer A Getz; Tobias D Schoep; Sejal S Hall; Erkki Ruoslahti; Patrick S Daugherty
Journal:  J Control Release       Date:  2012-05-23       Impact factor: 9.776

Review 8.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

9.  Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Authors:  Ann M Stowe; Tamer Altay; Angela B Freie; Jeffrey M Gidday
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

10.  MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent.

Authors:  Lisette H Deddens; Geralda A F van Tilborg; Annette van der Toorn; Kajo van der Marel; Leonie E M Paulis; Louis van Bloois; Gert Storm; Gustav J Strijkers; Willem J M Mulder; Helga E de Vries; Rick M Dijkhuizen
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.